Trial intelligence / Profile preview

Pantoprazole for cardiac and hepatic iron overload in thalassemia

IRCT2017042220258N40Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of pantoprazole in beta thalassemia major, beta-thalassemia intermedia and iron overload, sponsored by Arak University of Medical Sciences. Started Apr 2017; status: completed.

02

Drugs

pantoprazole
03

Conditions

beta thalassemia majorbeta-thalassemia intermediairon overload

Beyond the preview

Go deeper on IRCT2017042220258N40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017042220258N40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call